Overview

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
0
Participant gender:
All
Summary
This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Criteria
Other specific inclusion/exclusion criteria may apply. In order to determine eligibility,
further examination by the investigator is necessary.

Inclusion Criteria:

- Patients must have the signs and symptoms of pneumonia, with a chest xray showing a
pneumonia.

- The patient must have S. pneumoniae (a specific bacteria) growing in sputum or blood
to continue treatment.

Exclusion Criteria:

- Patients cannot have taken more than one day of another antibiotic before entering
this study.

- Patients with HIV and a low CD4 count are excluded.